MGI Statement
We are pleased to see that the jury invalidated the claim of United States Patent No. 7,541,444 asserted by Illumina in the trial in the Northern District of California. This patent contained the b...
More2021-12-01
News Center
Updates on MGI's developments in products.
Location：
Home /
News Center
MGI ATOPlex Technology Contributes to the Discovery of the First Case of COVID-19 Omicron Variant in SwedenThe newly discovered COVID-19 omicron variant (B.1.1.529), first identified in Botswana and South Africa, has recently spread rapidly to multiple countries around the world posing serious challenges t...More2021-11-30
HotMGI Showcases Latest Laboratory Automation Products at MEDICA 2021MESSE DÜSSELDORF, GERMANY, Nov. 15, 2021/PRNewswire/ — MGI Tech Co., Ltd. ("MGI"), a global life science leader and innovator, showcases a selection of its latest laboratory automation technologi...More2021-11-16
HotMGI Sequencing Platforms Contribute to the Surveillance and Tracing of COVID Variant in more than 10 Provinces in ChinaSince mid-October, the Chinese government has paid high attention to pandemic control and prevention due to a new outbreak of COVID-19. In response, MGI sequencing platforms have played an instrumenta...More2021-11-15
MGI DNBSEQ™ Sequencing Technology Empowers China Agricultural University in Pig BreedingWith the completion of genome sequencing of major agricultural species in recent years and the development of functional genomics and bioinformatics, livestock and poultry breeding has gradually trans...More2021-11-10
HotMGI Establishes Strategic Alliance with Industry Partners in Cancer Prevention and TreatmentShanghai, China, November 9, 2021 – MGI and Roche, together with Aisono and Shanzhen, officially formed a strategic alliance on "Early detection, Early diagnosis, and Early treatment" of Cancer at...More2021-11-09
